Related references
Note: Only part of the references are listed.p53 directs leader cell behavior, migration, and clearance during epithelial repair
Kasia Kozyrska et al.
SCIENCE (2022)
Functional Determinants of Cell Cycle Plasticity and Sensitivity to CDK4/6 Inhibition
Vishnu Kumarasamy et al.
CANCER RESEARCH (2021)
Icaritin inhibits PD-L1 expression by Targeting Protein IκB Kinase α
Dongliang Mo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
Liguo Wang et al.
NATURE CHEMICAL BIOLOGY (2021)
New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy
Marina Bury et al.
TRENDS IN CELL BIOLOGY (2021)
Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma
Xia Zheng et al.
FRONTIERS IN ONCOLOGY (2021)
Targeting CDK2 in cancer: challenges and opportunities for therapy
Solomon Tadesse et al.
DRUG DISCOVERY TODAY (2020)
Cyclin-dependent kinase 4 and 6 inhibitors for hormone receptor-positive breast cancer: past, present, and future
Laura M Spring et al.
LANCET (2020)
Cell cycle regulators in cancer cell metabolism
Lucia C. Leal-Esteban et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
p27 as a Transcriptional Regulator: New Roles in Development and Cancer
Seyedeh Fatemeh Razavipour et al.
CANCER RESEARCH (2020)
Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019)
Concepcion Sanchez-Martinez et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
Solomon Tadesse et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2019)
Interconnection between Metabolism and Cell Cycle in Cancer
Philippe Icard et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Identification of CDK2 as a novel target in treatment of prostate cancer
Xifeng Yin et al.
FUTURE ONCOLOGY (2018)
Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers
Masanori Kawakami et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds
Hongbin Huang et al.
FRONTIERS IN CHEMISTRY (2018)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2018)
Structural evidence of quercetin multi-target bioactivity: A reverse virtual screening strategy
Diego Carvalho et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Hepatic Stimulator Substance Resists Hepatic Ischemia/Reperfusion Injury by Regulating Drp1 Translocation and Activation
Chao Zhang et al.
HEPATOLOGY (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Reverse Pharmacognosy and Reverse Pharmacology; Two Closely Related Approaches for Drug Discovery Development
Soodabeh Saeidnia et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2016)
Type II Inhibitors Targeting CDK2
Leila T. Alexander et al.
ACS CHEMICAL BIOLOGY (2015)
Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced Apoptosis
Hongxing Han et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Alpha fetoprotein mediates HBx induced carcinogenesis in the hepatocyte cytoplasm
Chao Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2
Jingwei Li et al.
ONCOLOGY REPORTS (2015)
Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells
Li Sun et al.
MOLECULAR MEDICINE REPORTS (2015)
Icaritin suppresses the proliferation of human osteosarcoma cells in vitro by increasing apoptosis and decreasing MMP expression
Xiao-fang Wang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Anticancer effect of icaritin on human lung cancer cells through inducing s phase cell cycle arrest and apoptosis
Qian Zheng et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2014)
The Proliferation-Quiescence Decision Is Controlled by a Bifurcation in CDK2 Activity at Mitotic Exit
Sabrina L. Spencer et al.
CELL (2013)
Tumour selective targeting of cell cycle kinases for cancer treatment
Marieke Aarts et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
Shasha Li et al.
PLOS ONE (2013)
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Natalia G. Starostina et al.
TRENDS IN CELL BIOLOGY (2012)
Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells
N. Johnson et al.
BRITISH JOURNAL OF CANCER (2010)
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation
Per Hydbring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Protein kinase CK2 links extracellular growth factor signaling with the control of p27Kip1 stability in the heart
Ludger Hauck et al.
NATURE MEDICINE (2008)
Dynamic FoxO transcription factors
Haojie Huang et al.
JOURNAL OF CELL SCIENCE (2007)
CDK2 and FOXO1 - A fork in the road for cell fate decisions
Haojie Huang et al.
CELL CYCLE (2007)
CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage
Haojie Huang et al.
SCIENCE (2006)
Phosphorylation of progesterone receptor serine 400 mediates ligand-independent transcriptional activity in response to activation of cyclin-dependent protein kinase 2
LK Pierson-Mullany et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization
I Shin et al.
NATURE MEDICINE (2002)
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
J Liang et al.
NATURE MEDICINE (2002)
Share Paper
